Freeline Therapeutics Holdings plc (FRLN) has a market capitalization of $28.28M and trades at $6.49. The 52-week range is 2.11-8.745.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-22.52.
The stock has a beta of 0.66, operates in the Healthcare sector.
